ICON Plc - Company Profile
Powered by
All the data and insights you need on ICON Plc in one report.
- Save hours of research time and resources with
our up-to-date ICON Plc Strategy Report
- Understand ICON Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
ICON Plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides specialized services that span the entire lifecycle of product development. The company’s service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, provision of functional services, medical imaging, resourcing solutions, laboratory services and strategic support and tactical solutions for traditional, in vitro diagnostic and software devices. The company offers research services in areas of cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, non-alcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, and women’s health, among others. ICON is headquartered in Dublin, Ireland.
ICON Plc premium industry data and analytics
Products and Services
Services |
---|
Adaptive Trials |
Laboratory Services |
Functional Services Provision |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Acquisitions/Mergers/Takeovers | In February, the company acquired HumanFirst. |
2023 | New Products/Services | In September, the company launched next generation Clinical Trial Tokenisation solution. |
2023 | Contracts/Agreements | In September, the company entered into a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to execute a clinical trial to evaluate the effectiveness of next generation COVID-19 vaccine candidates. |
Competitor Comparison
Key Parameters | ICON Plc | IQVIA Holdings Inc | Laboratory Corp of America Holdings | Syneos Health Inc | Almac Group Ltd |
---|---|---|---|---|---|
Headquarters | Ireland | United States of America | United States of America | United States of America | United Kingdom |
City | Dublin | Durham | Burlington | Morrisville | Craigavon |
State/Province | Dublin | North Carolina | North Carolina | North Carolina | Northern Ireland |
No. of Employees | 41,100 | 87,000 | 67,000 | 28,768 | 6,600 |
Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Steve Cutler Ph.D | Director; Chief Executive Officer | Executive Board | 2017 | 62 |
Tom O'Leary | Chief Information Officer | Senior Management | - | - |
Diarmaid Cunningham | General Counsel; Secretary; Chief Administrative Officer | Senior Management | 2016 | 48 |
Joe Cronin | Chief Human Resources Officer | Senior Management | - | - |
George A. McMillan | Chief Commercial Officer | Senior Management | 2017 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer